DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.100_2630
Abstract: (HR (95% CI) = 0.600 (0.428-0.841)) . Multivariate Cox analysis with the interaction between treatment group and sCD30 level showed an increased risk of experiencing an mPFS event with ABVD and sCD30 >median (interaction p… read more here.
Keywords: dense abvd; abvd; dose dense; therapy ... See more keywords
Incidence of severe chemotherapy-associated nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-4526
Abstract: Introduction: Chemotherapy-induced nausea and vomiting (CINV) remains an important side effect of chemotherapy for patients with classical Hodgkin's Lymphoma (cHL). The BV-AVD (brentuximab vedotin- doxorubicin, vinblastine, dacarbazine) regimen for cHL improves overall survival in advanced… read more here.
Keywords: group; abvd; avd; nausea ... See more keywords